ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
1-Year Est. Return
11.37%
1 Year Est. Return
+11.37%
AUM
$5.71B
AUM Growth
-$696M
(-11%)
Holding
34
Top Buys
| 1 | +$187M | |
| 2 | +$65.1M | |
| 3 | +$20.2M | |
| 4 |
Vera Therapeutics
VERA
|
+$14.1M |
| 5 |
Alkermes
ALKS
|
+$12.9M |
Top Sells
| 1 | +$445M | |
| 2 | +$171M | |
| 3 | +$87.6M | |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$82.5M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
+$44.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
MannKind Corp
MNKD
$1.56B
| $21.9M | 0.38% |
5,850,000
-2,900,000
|
|
||
27
Monte Rosa Therapeutics
GLUE
$655M
| $16.8M | 0.29% |
3,725,000
-920,548
|
|
||
|
SEPN
28
Septerna Inc
SEPN
$1.04B
| $13.1M | 0.23% |
1,237,500
-100,000
|
|
||
29
Ultragenyx Pharmaceutical
RARE
$3.05B
| $12M | 0.21% |
330,000
-500,000
|
|
||
|
WHWK
30
Whitehawk Therapeutics
WHWK
$92.8M
| $5.33M | 0.09% |
2,849,402
|
|
||
|
AUTL
31
Autolus Therapeutics
AUTL
$458M
| – | – |
-9,910,642
|
|
||
32
Vaxcyte
PCVX
$5.56B
| – | – |
-1,000,000
|
|
||
33
Sarepta Therapeutics
SRPT
$2.32B
| – | – |
-2,674,835
|
|
||
|
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-625,000
|
|